IPO Wala
Accretion Pharmaceuticals IPO

Accretion Pharmaceuticals IPO

NSE SMEOpen for Subscription

May 14, 2025 - May 16, 2025

Exp. Premium: 18 (16.36 %)

₹ 121200/1200 Shares

*Expected Premium provided in this app is derived from market rumors. It is not a guaranteed indicator of the actual listing price and should be interpreted with caution.

Accretion Pharmaceuticals IPO Details

Open for Subscription
SME IPO

May 14, 2025

Open Date

May 16, 2025

Close Date

May 19, 2025

Allotment Date

May 21, 2025

Listing Date

Per Lot Price

121200

Price Range

110

Total Issue Size

29.75 Cr

Fresh Issue Size

29.75 Cr

Face Value

10

Listing at Group

NSE

Registrar

Kfin Technologies Limited

Lead Manager

Jawa Capital Services Private Limited

Offer For Sale

NIL

Subscription

0.15

Promoter Details

Mr. Mayur Popatlal Sojitra, Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel and Mr. Hardik Mukundbhai Prajapati are the promoters of the company

Market Lot Details

ApplicationLotsSharesAmount
Retail (Min)112001,21,200
Retail (Max)112001,21,200
HNI224002,42,400

Quota Details

CategoryPercentage (%)
QIB50%
HNI35%
Retail15%

Important Dates Timetable

Open Date
May 14, 2025
Close Date
May 16, 2025
Allotment Date
May 19, 2025
Initiation of Refunds
May 20, 2025
Credit of Shares to Demat
May 20, 2025
Listing Date
May 21, 2025

Objects Of The Issue

1. Capital expenditure towards the purchase of new equipment/machinery, etc

2.Capital expenditure towards the upgradation of existing manufacturing facility

3.Repayment/prepayment of certain borrowings availed by the Company.

4. Funding working capital requirements.

5. General Corporate Purpose.

Company Contact Details

Accretion Pharmaceuticals Limited
29 Xcelon Ind Park 1,
B/h, Intas Pharmaceuticals, Vasna Chacharvad
Sanand,
Phone: +91-97148 82929
Email[email protected]
Website: https://accretionpharma.com/

Registrar Details

Kfin Technologies Limited
Selenium, Tower B, Plot No 31 and 32, Financial District, Nanakramguda,
Serilingampally, Hyderabad, Telangana, 500032
Tel No.: +91 40 6716 2222/18003094001, E-mail: [email protected]
Investor Grievance Email: [email protected]
Website: www.kfintech.com
Contact Person: Mr. M. Murali Krishna
SEBI Registration No.: INR000000221

Manager Details

Jawa Capital Services Private Limited
Plot No. 93, First Floor, Pocket 2, Near DAV School, Jasola, New Delhi- 110025
Tel No.: +91-11-47366600; E-mail: [email protected]
Investor Grievance Email: [email protected]
Website: www.jawacapital.in
Contact Person: Mr. Taranveer Singh/ Mr. Sajal Gupta
SEBI Registration No.: MB/INM000012777

Accretion Pharmaceuticals IPO - FAQs

Q.What is the Accretion Pharmaceuticals IPO?
Ans.Accretion Pharmaceuticals is launching an IPO as a book_built_issue issue. The price band is ₹110 per share, and the lot size is 1200 shares.
Q.What are the opening and closing dates for Accretion Pharmaceuticals IPO?
Ans.The IPO opens on May 14, 2025 and closes on May 16, 2025.
Q.What is the expected Grey Market Premium (GMP) for Accretion Pharmaceuticals?
Ans.The current GMP for Accretion Pharmaceuticals IPO is ₹18 based on market speculations. Please note this value is collected from internet sources, and we do not promote it.
Q.When will the allotment for Accretion Pharmaceuticals IPO be finalized?
Ans.The IPO allotment will be finalized on May 19, 2025.
Q.When is the listing date for Accretion Pharmaceuticals IPO?
Ans.The IPO will be listed on NSE & BSE on May 21, 2025.
Q.How many times has Accretion Pharmaceuticals IPO been subscribed?
Ans.The IPO was subscribed 0.15 times as per the latest reports.
Q.What is the total issue size of Accretion Pharmaceuticals IPO?
Ans.The total issue size for Accretion Pharmaceuticals IPO is ₹29.75 Cr crore, including a fresh issue of ₹29.75 Cr crore and an Offer for Sale (OFS) of ₹NIL crore.
Q.Who is the registrar for Accretion Pharmaceuticals IPO?
Ans.The registrar for this IPO is Kfin Technologies Limited.
Q.Who are the lead managers for Accretion Pharmaceuticals IPO?
Ans.The lead managers for this IPO include: Jawa Capital Services Private Limited Plot No. 93, First Floor, Pocket 2, Near DAV School, Jasola, New Delhi- 110025 Tel No.: +91-11-47366600; E-mail: [email protected] Investor Grievance Email: [email protected] Website: www.jawacapital.in Contact Person: Mr. Taranveer Singh/ Mr. Sajal Gupta SEBI Registration No.: MB/INM000012777
Q.How can I check the allotment status of Accretion Pharmaceuticals IPO?
Ans.To check the allotment status, visit the registrar’s official website at https://kfintech.com.
Q.What is the financial performance of Accretion Pharmaceuticals?
Ans.Here are the financial highlights: N/A
Q.How can I contact Accretion Pharmaceuticals for more details?
Ans.You can reach Accretion Pharmaceuticals at: Address: Accretion Pharmaceuticals Limited 29 Xcelon Ind Park 1, B/h, Intas Pharmaceuticals, Vasna Chacharvad Sanand, Phone: +91-97148 82929 Email: [email protected] Website: https://accretionpharma.com/ Phone: N/A Email: N/A Website: N/A